About the Journal
CiteScore: 3.9
Impact Factor: 1.7
Our Mission
Launched in 2014 as the official journal of the Particle Therapy Co-Operative Group, it is the mission of IJPT to provide a preferred venue for disseminating the most up-to-date information on the clinical, physical, and biological research in proton, light-ion, and heavy charged-particle therapy. Since its founding, IJPT has published articles by nearly 300 prominent radiation oncologists, physicists, and dosimetrists from 200 institutions around the world.
The IJPT is a quarterly open access journal that does not charge any article submission or processing fees. Articles published in IJPT are distributed under the Creative Commons Attribution License (CC-BY). Articles are also digitally archived by PubMed Central, Portico, J-Gate, EBSCOhost, Google Scholar, the Directory of Open Access Journals (DOAJ), Web of Science, and Elsevier's Scopus, among others.
Our Review Process and Goals
The IJPT adheres to a blind peer review process for submitted manuscripts (i.e. the identities of the reviewers are concealed from the authors, but the authors are known to reviewers). Each paper is reviewed by at least two reviewers. The goals of the IJPT are to:
- assure an efficient means for dissemination of peer-reviewed information regarding particle therapy;
- become the preferred location for publication of all types of information regarding particle therapy;
- enhance the quality of particle therapy publications through dedicated and creative editorial assistance;
- facilitate career development of young particle therapy investigators; and
- embrace all aspects of diversity by welcoming multiple approaches and points of view that foster diversity and inclusion in research, writing, and review, while mitigating bias.
We welcome editorials, original articles, reports, and technical notes year-round at our online submission site.
Questions? Contact us.
Conflict of Interest Policy ♦ Conflict of Interest Disclosures for the IJPT Editorial Board ♦ Advertising/Revenue Policy
The IJPT Editorial Board
Editor-in-Chief |
Nancy P. Mendenhall, MD, FASTRO |
University of Florida Health Proton Therapy Institute |
USA |
Advisory Editor | William Mendenhall, MD, FACR, FASTRO | Dept. of Radiation Oncology, University of Florida | USA |
Journal Manager |
Liza Winthrop Grammel |
Dept. of Radiation Oncology |
USA |
Associate Editors |
Claire Alepetite, MD |
Institut Curie |
France |
|
Kwan Ho Cho, MD |
National Cancer Center |
Korea |
|
Lei Dong, PhD |
Dept. of Radiation Oncology, University of Pennsylvania |
USA |
|
Marco Durante, PhD |
GSI Helmholtzzentrum fur Schwerionenforschung |
Germany |
|
Steven J. Frank, MD |
UT MD Anderson Cancer Center |
USA |
|
Piero Fossati, PhD |
MedAustron |
Austria |
|
Brad Hoppe, MD, MPH |
Mayo Clinic |
USA |
|
Eugen Hug, MD |
MedAustron |
Austria |
|
Perry Johnson, PhD |
UF Health Proton Therapy Institute |
USA |
|
Tadashi Kamada, MD |
National Institute of Radiological Sciences |
Japan |
|
Karen Kirkby, PhD |
The University of Manchester |
UK |
|
Katja Langen, PhD |
Emory School of Medicine |
USA |
|
Nancy Lee, MD |
Memorial Sloan Kettering Cancer Center |
USA |
|
Shannon MacDonald, MD |
Massachusetts General Hospital |
USA |
|
Robert Mutter, MD |
Mayo Clinic |
USA |
Ester Orlandi, MD | National Center for Oncological Hadrontherapy (Fondazione CNAO) | Italy | |
|
Toshiyuki Toshito, PhD |
Nagoya Proton Therapy Center |
Japan |
|
Damien Weber, PhD |
Paul Scherrer Institut |
Switzerland |
|
Neha Vapiwala, MD |
University of Pennsylvania |
USA |
|
Marcelo Vazquez, MD, PhD |
Loma Linda University Medical Center |
USA |
|
X. Ronald Zhu, PhD |
MD Anderson Cancer Center |
USA |